The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...

Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian ...

Clade 1a is the older clade that has been linked to spillovers in animals and some limited human-to-human transmission in endemic areas. Clade 1a is thought to be more deadly and capable of causing ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

Brazil has reported its first clade 1b mpox case, per a notice from the national Health Ministry.

The individual who tested positive for mpox clade lb had recently traveled to Africa and is currently under the care of a physician and in isolation, according to state Health Commissioner Dr ...

The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...